• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For August 31, 2022

    8/31/22 5:53:39 AM ET
    $AI
    $ALVO
    $BNED
    $BNR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AI alert in real time by email

     

    Companies Reporting Before The Bell

    • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter.

    • Safe-T Gr (NASDAQ:SFET) is projected to report earnings for its second quarter.

    • Vera Bradley (NASDAQ:VRA) is likely to report earnings for its second quarter.

    • Brown Forman Inc Class B Common Stock (NYSE:BF) is expected to report quarterly earnings at $0.47 per share on revenue of $977.76 million.

    • Burning Rock Biotech (NASDAQ:BNR) is expected to report quarterly loss at $0.35 per share on revenue of $22.15 million.

    • VersaBank (NASDAQ:VBNK) is projected to report quarterly earnings at $0.21 per share on revenue of $19.29 million.

    • Chico's FAS (NYSE:CHS) is likely to report quarterly earnings at $0.25 per share on revenue of $543.90 million.

    • Barnes & Noble Education (NYSE:BNED) is projected to report quarterly loss at $0.57 per share on revenue of $250.84 million.

    • Evogene (NASDAQ:EVGN) is expected to report quarterly loss at $0.17 per share on revenue of $270 thousand.

    • Designer Brands (NYSE:DBI) is likely to report quarterly earnings at $0.52 per share on revenue of $838.69 million.

    • Express (NYSE:EXPR) is projected to report quarterly earnings at $0.09 per share on revenue of $479.62 million.

    • Donaldson (NYSE:DCI) is likely to report quarterly earnings at $0.84 per share on revenue of $880.24 million.

    • Brown Forman Inc Class A Common Stock (NYSE:BF) is estimated to report earnings for its first quarter.

    Companies Reporting After The Bell

    • Culp (NYSE:CULP) is expected to report quarterly loss at $0.28 per share on revenue of $58.21 million.

    • Semtech (NASDAQ:SMTC) is projected to report quarterly earnings at $0.85 per share on revenue of $208.29 million.

    • Okta (NASDAQ:OKTA) is expected to report quarterly loss at $0.31 per share on revenue of $430.68 million.

    • GBS (NASDAQ:GBS) is expected to report earnings for its fourth quarter.

    • Pure Storage (NYSE:PSTG) is likely to report quarterly earnings at $0.22 per share on revenue of $634.23 million.

    • Credo Technology Group (NASDAQ:CRDO) is estimated to report quarterly earnings at $0.03 per share on revenue of $45.70 million.

    • SentinelOne (NYSE:S) is estimated to report quarterly loss at $0.25 per share on revenue of $95.65 million.

    • Greif (NYSE:GEF) is expected to report quarterly earnings at $2.00 per share on revenue of $1.60 billion.

    • Cooper Companies (NYSE:COO) is expected to report quarterly earnings at $3.24 per share on revenue of $832.68 million.

    • Five Below (NASDAQ:FIVE) is projected to report quarterly earnings at $0.79 per share on revenue of $682.74 million.

    • C3.ai (NYSE:AI) is projected to report quarterly loss at $0.24 per share on revenue of $66.02 million.

    • MongoDB (NASDAQ:MDB) is expected to report quarterly loss at $0.28 per share on revenue of $282.39 million.

    • Nutanix (NASDAQ:NTNX) is estimated to report quarterly loss at $0.40 per share on revenue of $354.45 million.

    • Veeva Sys (NYSE:VEEV) is projected to report earnings for its second quarter.

    • Samsara (NYSE:IOT) is likely to report quarterly loss at $0.07 per share on revenue of $143.00 million.

    • Semantix (NASDAQ:STIX) is estimated to report earnings for its second quarter.

    • Alvotech (NASDAQ:ALVO) is projected to report earnings for its second quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AI
    $ALVO
    $BNED
    $BNR

    CompanyDatePrice TargetRatingAnalyst
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    The Cooper Companies Inc.
    $COO
    2/3/2026$100.00 → $99.00Buy
    Needham
    Credo Technology Group Holding Ltd
    $CRDO
    1/21/2026$170.00Neutral
    Rosenblatt
    Nutanix Inc.
    $NTNX
    1/15/2026$53.00Overweight → Equal Weight
    Barclays
    Samsara Inc.
    $IOT
    1/15/2026$40.00Neutral → Outperform
    BNP Paribas Exane
    Okta Inc.
    $OKTA
    1/14/2026$120.00Equal-Weight → Overweight
    Stephens
    Veeva Systems Inc.
    $VEEV
    1/13/2026$215.00Sell
    Goldman
    Five Below Inc.
    $FIVE
    1/13/2026$210.00Buy → Hold
    Jefferies
    More analyst ratings

    $AI
    $ALVO
    $BNED
    $BNR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Barrenechea Mark J was granted 24,741 shares (SEC Form 4)

    4/A - SentinelOne, Inc. (0001583708) (Issuer)

    2/6/26 8:29:40 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    President, CEO Weingarten Tomer sold $303,278 worth of shares (23,063 units at $13.15), decreasing direct ownership by 2% to 1,122,545 units (SEC Form 4)

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    2/6/26 8:29:01 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer & Sec'y Conder Keenan Michael sold $55,717 worth of shares (4,237 units at $13.15), decreasing direct ownership by 0.75% to 562,362 units (SEC Form 4)

    4 - SentinelOne, Inc. (0001583708) (Issuer)

    2/6/26 8:26:22 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    $AI
    $ALVO
    $BNED
    $BNR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $159,542 worth of Class B Common Stock (1,811 units at $88.10), increasing direct ownership by 37% to 6,730 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/6/26 4:47:40 PM ET
    $GEF

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $26,614 worth of Class B Common Stock (300 units at $88.71) and sold $992,419 worth of shares (13,337 units at $74.41), decreasing direct ownership by 27% to 36,807 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/5/26 2:45:27 PM ET
    $GEF

    EVP and CFO Hilsheimer Lawrence A. sold $1,636,150 worth of shares (22,778 units at $71.83) and bought $1,626,891 worth of Class B Common Stock (18,322 units at $88.79), increasing direct ownership by 1,334% to 207,416 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/5/26 1:32:35 PM ET
    $GEF

    $AI
    $ALVO
    $BNED
    $BNR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-2) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 10:44:05 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-1) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-3) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AI
    $ALVO
    $BNED
    $BNR
    SEC Filings

    View All

    Designer Brands Inc. filed SEC Form 8-K: Other Events

    8-K - Designer Brands Inc. (0001319947) (Filer)

    2/9/26 4:33:11 PM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    SEC Form 8-K filed by Five Below Inc.

    8-K - FIVE BELOW, INC (0001177609) (Filer)

    2/9/26 4:32:55 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Credo Technology Group Holding Ltd filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Credo Technology Group Holding Ltd (0001807794) (Filer)

    2/9/26 4:06:27 PM ET
    $CRDO
    Semiconductors
    Technology

    $AI
    $ALVO
    $BNED
    $BNR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Five Below upgraded by BofA Securities with a new price target

    BofA Securities upgraded Five Below from Underperform to Buy and set a new price target of $233.00

    2/4/26 8:24:40 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Needham reiterated coverage on Cooper with a new price target

    Needham reiterated coverage of Cooper with a rating of Buy and set a new price target of $99.00 from $100.00 previously

    2/3/26 7:02:57 AM ET
    $COO
    Ophthalmic Goods
    Health Care

    Rosenblatt initiated coverage on Credo Technology Group with a new price target

    Rosenblatt initiated coverage of Credo Technology Group with a rating of Neutral and set a new price target of $170.00

    1/21/26 8:55:06 AM ET
    $CRDO
    Semiconductors
    Technology

    $AI
    $ALVO
    $BNED
    $BNR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Credo Provides Preliminary Third Quarter Fiscal Year 2026 Revenue Results, Updated Revenue Guidance for Fourth Quarter of Fiscal Year 2026 and Schedules Third Quarter Fiscal Year 2026 Financial Results Conference Call

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today provided preliminary revenue results for the third quarter and updated revenue guidance for the fourth quarter of fiscal year 2026. Credo expects to report third quarter fiscal year 2026 revenue in the range of $404 million to $408 million, above the high-end of Credo's previously announced third quarter guidance range of $335 million and $345 million. Looking towards the end of fiscal year 2026 and into fiscal 2027, Credo expects sequential revenue growth in the mid-single digits leading to more than 200% year-ove

    2/9/26 4:05:00 PM ET
    $CRDO
    Semiconductors
    Technology

    Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board

    Appointments Strengthen Scientific Leadership and Support the Acceleration of ChemPass AI™ for Drug and Ag-Chemical Discovery REHOVOT, Israel, Feb. 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural industries, today announced the appointment of Prof. John J. Irwin of the University of California, San Francisco (UCSF), and Prof. Dan T. Major of Bar-Ilan University (BIU) to its scientific advisory board (SAB). The

    2/9/26 8:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    SentinelOne Delivers End-to-End AI Security from Data to Runtime

    New Data Security Capabilities Advance Unified Platform Approach to Securing the Full AI Lifecycle SentinelOne® (NYSE:S), the AI-native security leader, today announced the expansion of its AI Security Platform with new Data Security Posture Management (DSPM) capabilities designed to secure artificial intelligence (AI) systems from data ingestion through runtime execution. As a result, organizations can embrace AI adoption while ensuring they meet privacy and regulatory requirements, derisk data leakage concerns, and empower AI-driven innovation and automation with confidence. As AI usage moves from experimentation into widespread production, enterprises are facing a new category of ris

    2/6/26 9:09:00 AM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    $AI
    $ALVO
    $BNED
    $BNR
    Financials

    Live finance-specific insights

    View All

    Credo Provides Preliminary Third Quarter Fiscal Year 2026 Revenue Results, Updated Revenue Guidance for Fourth Quarter of Fiscal Year 2026 and Schedules Third Quarter Fiscal Year 2026 Financial Results Conference Call

    Credo Technology Group Holding Ltd (Credo) (NASDAQ:CRDO), an innovator in providing connectivity at scale through fast, reliable, and energy-efficient system solutions, today provided preliminary revenue results for the third quarter and updated revenue guidance for the fourth quarter of fiscal year 2026. Credo expects to report third quarter fiscal year 2026 revenue in the range of $404 million to $408 million, above the high-end of Credo's previously announced third quarter guidance range of $335 million and $345 million. Looking towards the end of fiscal year 2026 and into fiscal 2027, Credo expects sequential revenue growth in the mid-single digits leading to more than 200% year-ove

    2/9/26 4:05:00 PM ET
    $CRDO
    Semiconductors
    Technology

    SentinelOne Delivers End-to-End AI Security from Data to Runtime

    New Data Security Capabilities Advance Unified Platform Approach to Securing the Full AI Lifecycle SentinelOne® (NYSE:S), the AI-native security leader, today announced the expansion of its AI Security Platform with new Data Security Posture Management (DSPM) capabilities designed to secure artificial intelligence (AI) systems from data ingestion through runtime execution. As a result, organizations can embrace AI adoption while ensuring they meet privacy and regulatory requirements, derisk data leakage concerns, and empower AI-driven innovation and automation with confidence. As AI usage moves from experimentation into widespread production, enterprises are facing a new category of ris

    2/6/26 9:09:00 AM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    CooperCompanies Announces Release Date for First Quarter 2026

    SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com. About CooperCompaniesCooperCompanies (NASDAQ:COO) is a leading global medical device company focused on helping people experience life's beautiful mo

    2/5/26 4:15:00 PM ET
    $COO
    Ophthalmic Goods
    Health Care

    $AI
    $ALVO
    $BNED
    $BNR
    Leadership Updates

    Live Leadership Updates

    View All

    Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board

    Appointments Strengthen Scientific Leadership and Support the Acceleration of ChemPass AI™ for Drug and Ag-Chemical Discovery REHOVOT, Israel, Feb. 9, 2026 /PRNewswire/ -- Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational chemistry company focused on the AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural industries, today announced the appointment of Prof. John J. Irwin of the University of California, San Francisco (UCSF), and Prof. Dan T. Major of Bar-Ilan University (BIU) to its scientific advisory board (SAB). The

    2/9/26 8:00:00 AM ET
    $EVGN
    Agricultural Chemicals
    Industrials

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials

    Alvotech announces planned CEO succession and leadership transition

     - Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced key senior leadership changes following a planned succession process. Founder Róbert Wessman, who has served as Chairman since the company's inception in 2013 and Chief Executive Officer since 2023, will transition out of the CEO role at the end of the first quarter of 2026. He will continue to serve as Executive Chairman in a full-time capac

    1/6/26 7:15:00 AM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AI
    $ALVO
    $BNED
    $BNR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Designer Brands Inc.

    SC 13G/A - Designer Brands Inc. (0001319947) (Subject)

    12/12/24 6:00:14 PM ET
    $DBI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Samsara Inc.

    SC 13D/A - Samsara Inc. (0001642896) (Subject)

    12/11/24 9:27:25 PM ET
    $IOT
    EDP Services
    Technology